Lipocalin-2: Response to a short-term treadmill protocol in obese and normal-weight men

Journal of Human Sport and Exercise

Volumn 6, Issue 1, 2011, Pages 59-67

  Damirchi, Arsalan ^a   Rahmani Nia, Farhad ^a   Mehrabani, Javad ^a  

^a UNIVERSITY OF GUILAN   (Iran)

Author keywords

Adiposity; Inflammation; Lipocalin 2; Vigorous exercise

Indexed keywords

EID: 84865161061     PISSN: None     EISSN: 19885202     Source Type: Journal    
DOI: 10.4100/jhse.2011.61.07     Document Type: Article

References (29)

1. Berggren JR, Hulver MW, Houmard JA. Fat as an endocrine organ: influence of exercise. J Appl Physiol. 2005; 99:757-764. doi:10.1152/japplphysiol.00134.2005
2. Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982; 14:377-381.
3. Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J. 1973; 85:546-562.
4. Bruunsgaard H. The clinical impact of systemic low-level inflammation in elderly populations. Dan Med Bull. 2006; 53:285-309.
5. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL, Bouloumié A, Barbatelli G, Cinti S, Svensson PA, Barsh GS, Zucker JD, Basdevant A, Langin D, Clement K. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005; 54:2277-2286.
6. Choi KM, Kim TN, Yoo HJ, Lee KW, Cho GJ, Hwang TG, Baik SH, Choi DS, Kim SM. Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women. Clin Endocrin. 2009; 70:569-574.
7. Choi KM, Lee JS, Kim EJ, Baik SH, Seo HS, Choi DS, Oh DJ, Park CG. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol. 2008; 158:203-207. doi:10.1530/EJE-07-0633
8. Ciolac EG, Guimaraes GV. Physical exercise and metabolic syndrome. Rev Bras Med Esporte. 2004; 10:325-330. doi:10.1900/RDS.2006.3.118.
9. Cowland JB, Muta T, Borregaard N. IL-1β-specific upregulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. J Immunol. 2006; 176:5559-66.
10. Damirchi A, Babaei P, Arazi H. Acute phase response of immune system to single and repeated bouts of selected exercise in a day. Thesis for the degree of doctor of sport physiology. 2008.
11. Esteve E, Ricart W, Fernández-Real JM. Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care. 2009; 32(2):S362-S367. doi:10.2337/dc09-S340
12. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004; 432:917-921.
13. Mathur N, Pedersen BK. Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm. 2008; 1-6. doi:10.1155/2008/109502.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412-419.
15. Mohebbi H, Moghadasi M, Rahmani-Nia F, Hassan-Nia S, Noroozi H. Association among lifestyle status, plasma adiponectin level and metabolic syndrome in obese middle aged men. Br J Biomotricity. 2009; 3:243-252.
16. Nieman DC. Fitness and sports medicine: An introduction. Bull Publishing Company; 1990. Pp. 70-76.
17. Paczeck BC, Bartlomiejczyk I, Gabrys T, Przybylski J, Nowak M, Paczeck L. Lack of relationship between interleukin-6 and CRP levels in healthy male athletes. Immonol Let. 2005; 99:136-140.
18. Pedersen BK, Steensberg A, Fischer C, Keller C, Ostrowski K, Schjerling P. Exercise and cytokines with particular focus on muscle-derived IL-6. Exerc Immunol Rev. 2001; 7:18-31.
19. Petersen AMW, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol. 2005; 98:1154-1162.
20. Ross R. Atherosclerosis, an inflammatory disease. N Engl J Med. 1999; 340:115-126.
21. Sommer G, Weise S, Kralisch S, Lossner U, Bluher M, Stumvoll M, Fasshauer M. Lipocalin-2 is induced by interleukin-1 β in murine adipocytes in vitro. J Cell Biochemistry. 2009; 106:103-108.
22. Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K, Sugawara K. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev. 2002; 8:6-48.
23. Suzuki K, Yamada M, Kurakake S, Okamura N, Yamaya K, Liu Q, Kudoh S, Kowatari K, Nakaji S, Sugawara K. Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans. Eur J Appl Physiol. 2000; 81:281-287.
24. Tan B, Adya R, Iaoye X, Syed F, Lewandowski KC, O'hare JP, Randeva H. Ex vivo and in vivo regulation of Lipocalin-2, a novel adipokine, by Insulin. Diabetes Care. 2009; 32:129-131. doi:10.2337/dc08-1236
25. Tataranni PA, Ortega E. A burning question: does an adipokineinduced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes. 2005; 54:917-927.
26. Vandam RM, Hu FB. Lipocalins and insulin resistance: etiological role of retinol-binding protein 4 and lipocalin-2? Clin Chem. 2007; 53(1):5-7.
27. Wang Y, Lam KSL, Kraegen EW, Sweeney G, Zhang J, Tso AWK, Chow WS, Wat NMS, Xu JY, Hoo RLC, Xu A. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem. 2007; 53(1):34-41.
28. Yan QW, Yang Q, Mody N, Graham TE, Hsu CH, Xu Z, Houstis NE, Kahn BB, Rosen ED. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes. 2007; 6(10):2533-2540.
29. Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA, Chen X. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Molec Endocrin. 2008; 22(6):1416-1426.